欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/V/0025/001
药品名称Kelactin 50 µg/ml oral solution
活性成分
    • cabergoline 50.0 µg/ml
剂型Oral solution
上市许可持有人Veyx-Pharma GmbH Söhreweg 6 34639 Schwarzenborn Germany
参考成员国 - 产品名称Belgium (BE)
Kelactin 50 microgram /ml
互认成员国 - 产品名称
    • Germany (DE)
      Kelactin
    • Denmark (DK)
      Kelactin
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
      Kelactin
    • France (FR)
      KELACTIN 50 µG/ML SOLUTION BUVABLE (13189)
    • Portugal (PT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Hungary (HU)
    • Cyprus (CY)
    • Italy (IT)
    • Czechia (CZ)
    • Spain (ES)
    • Slovakia (SK)
    • Poland (PL)
许可日期2012/01/25
最近更新日期2023/07/26
药物ATC编码
    • QG02CB03 cabergoline
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase